DIOS-CoVax clinical trial recruitment and analysis

利用DIOSynVax技术开发出了预防多种相关病毒的疫苗。对于SARS-COV-2和SARS-COV等冠状病毒，需要采取这种广泛的保护措施，这两种相关病毒有可能在未来从人畜共患宿主中引起疫情。我们设计了抗原来诱导针对sarbecovirus的免疫反应，以防止当前的大流行和未来相关冠状病毒的爆发。这种疫苗采用无针注射技术，使患者的细胞产生抗原，这些抗原被免疫系统识别，从而诱导对SARS-CoV-2和相关冠状病毒的保护。

Vaccines that protect against multiple related viruses have been developed using DIOSynVax technology. This broadly protective approach is needed for the Coronaviruses such as SARS-COV-2 and SARS-COV, two of numerous related viruses that have the potential to cause future outbreaks from zoonotic reservoirs. We have designed antigens to induce an immune response against the Sarbecoviruses in order to protect against the current pandemic and future outbreaks of related Coronaviruses. This vaccine is administered using a needleless technology causing patients' cells to produce the antigens, which are recognized by the immune system to induce protection against SARS-CoV-2 and related Coronaviruses.